139 related articles for article (PubMed ID: 22785496)
1. Visual assessment versus quantitative three-dimensional stereotactic surface projection fluorodeoxyglucose positron emission tomography for detection of mild cognitive impairment and Alzheimer disease.
Lehman VT; Carter RE; Claassen DO; Murphy RC; Lowe V; Petersen RC; Peller PJ
Clin Nucl Med; 2012 Aug; 37(8):721-6. PubMed ID: 22785496
[TBL] [Abstract][Full Text] [Related]
2. A modified method of 3D-SSP analysis for amyloid PET imaging using [¹¹C]BF-227.
Kaneta T; Okamura N; Minoshima S; Furukawa K; Tashiro M; Furumoto S; Iwata R; Fukuda H; Takahashi S; Yanai K; Kudo Y; Arai H
Ann Nucl Med; 2011 Dec; 25(10):732-9. PubMed ID: 21792587
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of 3-dimensional stereotactic surface projection FDG PET images for the diagnosis of dementia.
Kim J; Cho SG; Song M; Kang SR; Kwon SY; Choi KH; Choi SM; Kim BC; Song HC
Medicine (Baltimore); 2016 Dec; 95(49):e5622. PubMed ID: 27930593
[TBL] [Abstract][Full Text] [Related]
4. Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
Lange C; Suppa P; Frings L; Brenner W; Spies L; Buchert R
J Alzheimers Dis; 2016; 49(4):945-959. PubMed ID: 26577523
[TBL] [Abstract][Full Text] [Related]
5. A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.
Iaccarino L; Chiotis K; Alongi P; Almkvist O; Wall A; Cerami C; Bettinardi V; Gianolli L; Nordberg A; Perani D
J Alzheimers Dis; 2017; 59(2):603-614. PubMed ID: 28671117
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer disease: improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections.
Burdette JH; Minoshima S; Vander Borght T; Tran DD; Kuhl DE
Radiology; 1996 Mar; 198(3):837-43. PubMed ID: 8628880
[TBL] [Abstract][Full Text] [Related]
7. Fully automatic diagnostic system for early- and late-onset mild Alzheimer's disease using FDG PET and 3D-SSP.
Ishii K; Kono AK; Sasaki H; Miyamoto N; Fukuda T; Sakamoto S; Mori E
Eur J Nucl Med Mol Imaging; 2006 May; 33(5):575-83. PubMed ID: 16470370
[TBL] [Abstract][Full Text] [Related]
8. Longer-Term Investigation of the Value of 18F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer's Disease: A Multicenter Study.
Inui Y; Ito K; Kato T;
J Alzheimers Dis; 2017; 60(3):877-887. PubMed ID: 28922157
[TBL] [Abstract][Full Text] [Related]
9. Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT.
Chiba Y; Iseki E; Fujishiro H; Ota K; Kasanuki K; Suzuki M; Hirayasu Y; Arai H; Sato K
Psychiatry Res Neuroimaging; 2016 Mar; 249():105-12. PubMed ID: 26857415
[TBL] [Abstract][Full Text] [Related]
10. Equal sensitivity of early and late scans after injection of FDG for the detection of Alzheimer pattern: an analysis of 3D PET data from J-ADNI, a multi-center study.
Takahashi R; Ishii K; Senda M; Ito K; Ishii K; Kato T; Makishi Y; Nishio T; Ikari Y; Iwatsubo T;
Ann Nucl Med; 2013 Jun; 27(5):452-9. PubMed ID: 23483370
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Visual and Quantitative Florbetapir F 18 Positron Emission Tomography Analysis in Predicting Mild Cognitive Impairment Outcomes.
Schreiber S; Landau SM; Fero A; Schreiber F; Jagust WJ;
JAMA Neurol; 2015 Oct; 72(10):1183-90. PubMed ID: 26280102
[TBL] [Abstract][Full Text] [Related]
12. Fully automatic differential diagnosis system for dementia with Lewy bodies and Alzheimer's disease using FDG-PET and 3D-SSP.
Kono AK; Ishii K; Sofue K; Miyamoto N; Sakamoto S; Mori E
Eur J Nucl Med Mol Imaging; 2007 Sep; 34(9):1490-7. PubMed ID: 17318545
[TBL] [Abstract][Full Text] [Related]
13. Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.
Xu L; Wu X; Li R; Chen K; Long Z; Zhang J; Guo X; Yao L;
J Alzheimers Dis; 2016; 51(4):1045-56. PubMed ID: 26923024
[TBL] [Abstract][Full Text] [Related]
14. Visualization and Quantification of 3-Dimensional Stereotactic Surface Projections for 18F-Flutemetamol PET Using Variable Depth.
Lilja J; Thurfjell L; Sörensen J
J Nucl Med; 2016 Jul; 57(7):1078-83. PubMed ID: 26912445
[TBL] [Abstract][Full Text] [Related]
15. Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients.
Choo IH; Ni R; Schöll M; Wall A; Almkvist O; Nordberg A
J Alzheimers Dis; 2013; 33(4):929-39. PubMed ID: 23047371
[TBL] [Abstract][Full Text] [Related]
16. Analysis of early phase [11C]BF-227 PET, and its application for anatomical standardization of late-phase images for 3D-SSP analysis.
Kaneta T; Okamura N; Arai A; Takanami K; Furukawa K; Tashiro M; Furumoto S; Iwata R; Takahashi S; Arai H; Yanai K; Kudo Y
Jpn J Radiol; 2014 Mar; 32(3):138-44. PubMed ID: 24408078
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment.
Zhang S; Han D; Tan X; Feng J; Guo Y; Ding Y
Int J Clin Pract; 2012 Feb; 66(2):185-98. PubMed ID: 22257044
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.
Morbelli S; Bauckneht M; Arnaldi D; Picco A; Pardini M; Brugnolo A; Buschiazzo A; Pagani M; Girtler N; Nieri A; Chincarini A; De Carli F; Sambuceti G; Nobili F
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2073-2083. PubMed ID: 28785843
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy.
Smailagic N; Lafortune L; Kelly S; Hyde C; Brayne C
J Alzheimers Dis; 2018; 64(4):1175-1194. PubMed ID: 30010119
[TBL] [Abstract][Full Text] [Related]
20. A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PET.
Etminani K; Soliman A; Davidsson A; Chang JR; Martínez-Sanchis B; Byttner S; Camacho V; Bauckneht M; Stegeran R; Ressner M; Agudelo-Cifuentes M; Chincarini A; Brendel M; Rominger A; Bruffaerts R; Vandenberghe R; Kramberger MG; Trost M; Nicastro N; Frisoni GB; Lemstra AW; van Berckel BNM; Pilotto A; Padovani A; Morbelli S; Aarsland D; Nobili F; Garibotto V; Ochoa-Figueroa M
Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):563-584. PubMed ID: 34328531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
